ESC 365 - Therapeutic miR-132 inhibition reverses heart failure

ESC Premium Access

Therapeutic miR-132 inhibition reverses heart failure

Session: Late Breaking Basic and Translational Science - Acute Coronary Syndromes and Heart Failure

Topic: Experimental Heart Failure

Speaker: Professor T. Thum (Hannover, DE)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Thomas Thum

Institute for Molecular and Translational Therapeutic Strategies (IMTTS), Hannover (Germany)

27 presentations

1 follower

4 more presentations in this session

Exome variants influencing cholesterol levels and the risk of recurrent ischemic events after early-onset myocardial infarction

Speaker: Doctor D. Ardissino (Ospedale parma, IT)

In silico model for specific antigen-driven response of T-lymphocytes in the epicardial adipose tissue: unravelling the intricate skein of microbiota involvement in acute coronary syndromes

Speaker: Doctor D. Pedicino (Rome, IT)

A different microbial signature in plaque and gut of patients presenting with ACS: a possible role for coronary instability

Speaker: Doctor P. Eugenia (Rome, IT)

Circulating dipeptidyl peptidase-3 is a myocardial depressant factor: Procizumab promptly and sustainably restored hemodynamics in heart failure

Speaker: Professor A. Mebazaa (Paris, FR)

Access the full session

Late Breaking Basic and Translational Science - Acute Coronary Syndromes and Heart Failure

Speakers: Professor T. Thum, Doctor D. Ardissino, Doctor D. Pedicino, Doctor P. Eugenia, Professor A. Mebazaa

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources